Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

MedImmune FluMist Sales Of $30 Mil. Expected; 50% Return Rate Possible

  • News

Executive Summary

MedImmune expects to record about $30 mil. of sales-related revenue for the FluMist nasal flu vaccine during the 2003-2004 launch season

You may also be interested in...



Aventis Fluzone Distribution Will Be Monitored In Partnership With CDC

Sanofi-Aventis will be working with the Centers for Disease Control & Prevention to monitor distribution of about 25.4 mil. remaining doses of Fluzone to U.S. providers

Aventis Fluzone Distribution Will Be Monitored In Partnership With CDC

Sanofi-Aventis will be working with the Centers for Disease Control & Prevention to monitor distribution of about 25.4 mil. remaining doses of Fluzone to U.S. providers

FluMist Price Likely To Be Cut To $20-$25 Per Dose, MedImmune Says

MedImmune is considering reducing the price for the intranasal flu vaccine FluMist to $20-$25 per dose for the 2004-2005 season, CEO David Mott indicated during a first quarter conference call April 21

Table

View full table

Related Content

Pink Sheet
Pink Sheet
Pink Sheet
Pink Sheet
Tags:
Latest Headlines

Pharma Can Pursue Claims Against Providers For 340B Duplicate Discounts In Medicaid Managed Care, HRSA Says

The Aspirin Test For AI?

Mary Beth Clarke, CDER Exec Programs Office Director And Generic User Fee Shepherd, Will Retire

Rx Advertising: Interchangeability Doesn’t Mean Clinical Superiority To Other Biosimilars, FDA Says

See All
UsernamePublicRestriction

Register

PS043262

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By